Explore groundbreaking studies on DNA methylation, histone modifications, and non-coding RNA mechanisms
Explore how the novel HDAC6 inhibitor N-(4-chlorophenyl)-4-phenylbutanamide demonstrates anti-cancer activity against cervix cancer and leukemia cells through epigenetic mechanisms.